Skip to content
Life Sciences Seed Founded 2023

Surf

Developer of non-invasive ultrasound neuromodulation platform for chronic inflammatory disorders

📍 United States · Pain Management

Funding snapshot

Last roundSeed
Amount$6M
Date10 April 2026

About

Developer of non-invasive ultrasound neuromodulation platform for chronic inflammatory disorders. It focuses on stimulating the spleen-brain axis to control inflammation. The technology uses broad-beam ultrasound to activate nerves, releasing neurotransmitters that signal the immune system. This aims to restore immune balance and provide relief from inflammation. The platform is being developed to treat autoimmune disorders without drugs.

Latest news

No articles yet.

Raising like Surf?

Analyze your pitch deck before your next raise.

Analyze My Deck →